| Clinical data | |
|---|---|
| Synonyms | 5-Ethyl-5-phenylhydantoin |
| Routes of administration |
By mouth |
| ATC code |
|
| Identifiers | |
|
|
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ECHA InfoCard | 100.010.138 |
| Chemical and physical data | |
| Formula | C11H12N2O2 |
| Molar mass | 204.22518 |
| 3D model (JSmol) | |
|
|
|
|
Nirvanol, also known as ethylphenylhydantoin, is a derivative of hydantoin with anticonvulsant properties. Its 5-ethyl-5-phenyl substitution pattern is similar to that of phenobarbital. It is useful in the treatment of chorea.
Metabolism of nirvanol is stereoselective, with the (S)- enantiomer undergoing roughly 14 times more hydroxylation at the 4 position of the phenyl group than the (R)-enantiomer.